GC Wealth Management RIA, LLC

Position in MRK — Merck & Co., Inc.

CIK 2011169 Cambridge, MA

Position in MRK

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$5,022,936

+$26,451 QoQ

Shares Held

39,089

-5.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#1,043

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GC Wealth Management RIA, LLC holds $51,496,913 across 12 Drug Manufacturers - General names. MRK ranks #3 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	18,328	$21,983,154
2	ABBV	AbbVie Inc.	37,102	$9,336,347
3	MRK	Merck & Co., Inc. This page	39,089	$5,022,936
4	JNJ	Johnson & Johnson	18,773	$4,767,778
5	AZN	Astrazeneca PLC	18,143	$3,440,275
6	AMGN	Amgen Inc	6,073	$2,199,154
7	NVO	Novo Nordisk A S	39,641	$1,900,389
8	NVS	Novartis AG	6,349	$995,015

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,022,936	39,089	-5.9%	Shares	Sole	2026-07-16
2026-03-31	$4,996,485	41,537	-5.8%	Shares	Sole	2026-05-14
2025-12-31	$4,639,545	44,077	-33.6%	Shares	Sole	2026-01-30
2025-09-30	$5,574,042	66,413	+194.2%	Shares	Sole	2025-11-13
2025-06-30	$1,787,195	22,577	-22.1%	Shares	Sole	2025-07-17
2025-03-31	$2,600,975	28,977	+4.4%	Shares	Sole	2025-05-12
2024-12-31	$2,760,271	27,747	+29.3%	Shares	Sole	2025-02-07
2024-09-30	$2,437,338	21,463	+21.0%	Shares	Sole	2024-11-04
2024-06-30	$2,195,221	17,732	+3.9%	Shares	Sole	2024-07-31
2024-03-31	$2,251,067	17,060	+61.9%	Shares	Sole	2024-05-10
2023-12-31	$1,148,852	10,538	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.